![[Translate to English:] [Translate to English:]](/files/_processed_/e/1/csm_OB_GL2025_0570_Final_379a68c130.jpeg)
Interview | Martin Böhm, Chief Experience Officer at Ottobock
“We shouldn't think of diversity as a corrective measure, but as a design principle.“
![[Translate to English:] [Translate to English:]](/files/_processed_/e/1/csm_OB_GL2025_0570_Final_379a68c130.jpeg)
“We shouldn't think of diversity as a corrective measure, but as a design principle.“

36 trillion cells, 400 cell types, 60 different tissues and organs: The sheer volume and complexity explain why changes are often not detected at the onset of a disease, but only when the first symptoms become apparent.
This is where the Einstein…

IKIM: A hub for AI in medicine

“Lusatia has the potential to be a pioneer by national standards. The principles are transferable: Networking, administrative relief and patient-centered care work everywhere.”
The Einstein Center Digital Future, known as the ECDF, is a Berlin-based centre for digitalisation research. It stands for independent, interdisciplinary research into the shaping and critical reflection of digital transformation, developed in…

NeuroTech Open Innovation Hub – Accelerating the Translation to Application for NeuroTech Innovation
![[Translate to English:] [Translate to English:]](/files/_processed_/0/e/csm_Aleksandar_-_Recare__1___1__b55d6b571a.jpg)
Aleksandar Ivanovski is a senior machine learning engineer at Recare, a Berlin-based company that has been developing digital discharge management for hospitals since 2017 and now connects more than 700 acute care clinics.
Dr. Sievert Weiss is a physician, co-founder, and medical director of AMBOSS. Since its founding, he and an interdisciplinary team have pursued the goal of making medical knowledge available where it is needed in everyday clinical practice.
For more than 20 years, JPT Peptide Technologies has been producing peptides for scientific purposes and the pharmaceutical industry in Berlin. In the year 2009, the biotech company was acquired by Mainz-based BioNTech SE and has since grown…
“Berlin's vibrant healthtech and AI ecosystem is a crucial component of Bayer's success”